ArticleGland surgery2022

Determining the benefit of neoadjuvant chemotherapy in reduction of axillary dissection rates in Z0011 trial cohort with high nodal burden.

Zhiyan Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.